129 related articles for article (PubMed ID: 17600973)
1. Phase III microbicide trial methodology: opinions of experienced expanded safety trial participants in South Africa.
van de Wijgert J; Jones H; Pistorius A; de Kock A; Sebola M; Friedland B; Hoosen A; Coetzee N
SAHARA J; 2005 Nov; 2(3):311-9. PubMed ID: 17600973
[TBL] [Abstract][Full Text] [Related]
2. The effectiveness of Carraguard, a vaginal microbicide, in protecting women against high-risk human papillomavirus infection.
Marais D; Gawarecki D; Allan B; Ahmed K; Altini L; Cassim N; Gopolang F; Hoffman M; Ramjee G; Williamson AL
Antivir Ther; 2011; 16(8):1219-26. PubMed ID: 22155903
[TBL] [Abstract][Full Text] [Related]
3. Acceptability of Carraguard vaginal microbicide gel among HIV-infected women in Chiang Rai, Thailand.
Whitehead SJ; McLean C; Chaikummao S; Braunstein S; Utaivoravit W; van de Wijgert JH; Mock PA; Siraprapasiri T; Friedland BA; Kilmarx PH; Markowitz LE
PLoS One; 2011; 6(9):e14831. PubMed ID: 21915249
[TBL] [Abstract][Full Text] [Related]
4. Hidden heterogeneity: Uncovering patterns of adherence in microbicide trials for HIV prevention.
Miller L; Prieto Merino D; Baisley K; Hayes R
PLoS One; 2022; 17(5):e0267011. PubMed ID: 35551324
[TBL] [Abstract][Full Text] [Related]
5. Male Partner Influence on Women's HIV Prevention Trial Participation and Use of Pre-exposure Prophylaxis: the Importance of "Understanding".
Montgomery ET; van der Straten A; Stadler J; Hartmann M; Magazi B; Mathebula F; Laborde N; Soto-Torres L
AIDS Behav; 2015 May; 19(5):784-93. PubMed ID: 25416076
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of Carraguard for prevention of HIV infection in women in South Africa: a randomised, double-blind, placebo-controlled trial.
Skoler-Karpoff S; Ramjee G; Ahmed K; Altini L; Plagianos MG; Friedland B; Govender S; De Kock A; Cassim N; Palanee T; Dozier G; Maguire R; Lahteenmaki P
Lancet; 2008 Dec; 372(9654):1977-87. PubMed ID: 19059048
[TBL] [Abstract][Full Text] [Related]
7. 'The study has taught me to be supportive of her': empowering women and involving men in microbicide research.
Venables E; Stadler J
Cult Health Sex; 2012; 14(2):181-94. PubMed ID: 22085043
[TBL] [Abstract][Full Text] [Related]
8. The relationship between vaginal ring use and intimate partner violence and social harms: formative research outcomes from the CHARISMA study in Johannesburg, South Africa.
Hartmann M; Palanee-Phillips T; O'Rourke S; Adewumi K; Tenza S; Mathebula F; Wagner D; Ayub A; Montgomery ET
AIDS Care; 2019 Jun; 31(6):660-666. PubMed ID: 30309246
[TBL] [Abstract][Full Text] [Related]
9. Changes in sexual behavior during a safety and feasibility trial of a microbicide/diaphragm combination: an integrated qualitative and quantitative analysis.
Guest G; Johnson L; Burke H; Rain-Taljaard R; Severy L; von Mollendorf C; Van Damme L
AIDS Educ Prev; 2007 Aug; 19(4):310-20. PubMed ID: 17685844
[TBL] [Abstract][Full Text] [Related]
10. The acceptability of an investigational vaginal microbicide, PRO 2000 Gel, among women in a phase I clinical trial.
Morrow K; Rosen R; Richter L; Emans A; Forbes A; Day J; Morar N; Maslankowski L; Profy AT; Kelly C; Abdool Karim SS; Mayer KH
J Womens Health (Larchmt); 2003 Sep; 12(7):655-66. PubMed ID: 14583106
[TBL] [Abstract][Full Text] [Related]
11. Optimizing HIV prevention for women: a review of evidence from microbicide studies and considerations for gender-sensitive microbicide introduction.
Doggett EG; Lanham M; Wilcher R; Gafos M; Karim QA; Heise L
J Int AIDS Soc; 2015; 18(1):20536. PubMed ID: 26700845
[TBL] [Abstract][Full Text] [Related]
12. The role of partnership dynamics in determining the acceptability of condoms and microbicides.
Montgomery CM; Lees S; Stadler J; Morar NS; Ssali A; Mwanza B; Mntambo M; Phillip J; Watts C; Pool R
AIDS Care; 2008 Jul; 20(6):733-40. PubMed ID: 18576176
[TBL] [Abstract][Full Text] [Related]
13. Baseline Predictors of High Adherence to a Coitally Dependent Microbicide Gel Based on an Objective Marker of Use: Findings from the Carraguard Phase 3 Trial.
Friedland BA; Stoner M; Chau MM; Plagianos MG; Govender S; Morar N; Altini L; Skoler-Karpoff S; Ahmed K; Ramjee G; Monedi C; Maguire R; Lähteenmäki P
AIDS Behav; 2016 Nov; 20(11):2565-2577. PubMed ID: 26204987
[TBL] [Abstract][Full Text] [Related]
14. Intravaginal practices and microbicide acceptability in Papua New Guinea: implications for HIV prevention in a moderate-prevalence setting.
Vallely A; Fitzgerald L; Fiya V; Aeno H; Kelly A; Sauk J; Kupul M; Neo J; Millan J; Siba P; Kaldor JM
BMC Res Notes; 2012 Nov; 5():613. PubMed ID: 23116431
[TBL] [Abstract][Full Text] [Related]
15. "We have our protector": misperceptions of protection against HIV among participants in a microbicide efficacy trial.
Mantell JE; Morar NS; Myer L; Ramjee G
Am J Public Health; 2006 Jun; 96(6):1073-7. PubMed ID: 16670239
[TBL] [Abstract][Full Text] [Related]
16. Expanded safety and acceptability of the candidate vaginal microbicide Carraguard® in South Africa.
Carraguard Phase II South Africa Study Team
Contraception; 2010 Dec; 82(6):563-71. PubMed ID: 21074021
[TBL] [Abstract][Full Text] [Related]
17. To tell or not to tell: male partner engagement in a Phase 3 microbicide efficacy trial in South Africa.
Kelly CA; Friedland BA; Morar NS; Katzen LL; Ramjee G; Mokgatle MM; Ahmed K
Cult Health Sex; 2015; 17(8):1004-20. PubMed ID: 25913101
[TBL] [Abstract][Full Text] [Related]
18. Predictors of using a microbicide-like product among adolescent girls.
Short MB; Succop PA; Ugueto AM; Rosenthal SL
J Adolesc Health; 2007 Oct; 41(4):357-62. PubMed ID: 17875461
[TBL] [Abstract][Full Text] [Related]
19. Engaging male partners in women's microbicide use: evidence from clinical trials and implications for future research and microbicide introduction.
Lanham M; Wilcher R; Montgomery ET; Pool R; Schuler S; Lenzi R; Friedland B
J Int AIDS Soc; 2014; 17(3 Suppl 2):19159. PubMed ID: 25224618
[TBL] [Abstract][Full Text] [Related]
20. Educating men about vaginal microbicides: considerations from Kenya.
Gitome SW; Kwena ZA; Harper CC; Cohen CR; Bukusi EA
Cult Health Sex; 2020 Jun; 22(6):660-674. PubMed ID: 31241426
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]